NexImmune News

Analysts Offer Insights on Healthcare Companies: Viking Therapeutics (VKTX), NexImmune (NEXI) and Biomea Fusion (BMEA)

TipRanksMar 29, 2023 06:06 ET

NexImmune Analyst Ratings

Benzinga Analyst RatingsNov 16, 2022 07:28 ET

NexImmune Analyst Ratings

Benzinga Analyst RatingsNov 15, 2022 06:42 ET

NexImmune (NEXI) Gets a Buy From Raymond James

TipRanksAug 16, 2022 08:45 ET

NexImmune (NEXI) Receives a Buy From Barclays

TipRanksAug 16, 2022 08:45 ET

Neximmune Is Maintained at Overweight by Barclays

Dow JonesAug 16, 2022 08:15 ET

Neximmune Price Target Cut to $2.00/Share From $7.00 by Barclays

Dow JonesAug 16, 2022 08:15 ET

Barclays Maintains Overweight on NexImmune, Lowers Price Target to $2

Benzinga Real-time NewsAug 16, 2022 08:06 ET

NexImmune Price Target Cut By 75%, Plus Wells Fargo Lowers PT Price Target On These Stocks

Benzinga Real-time NewsAug 16, 2022 07:50 ET

Neximmune Is Maintained at Outperform by Raymond James

Dow JonesAug 16, 2022 07:39 ET

NexImmune Analyst Ratings

Benzinga Analyst RatingsAug 16, 2022 07:30 ET

Raymond James Maintains Outperform on NexImmune, Lowers Price Target to $3

Benzinga Real-time NewsAug 16, 2022 07:30 ET

BTIG Reaffirms Their Buy Rating on NexImmune (NEXI)

TipRanksAug 16, 2022 05:00 ET

Cantor Fitzgerald Adjusts Price Target for NexImmune to $4 From $35, Maintains Overweight

MT NewswiresJun 30, 2022 22:08 ET

BTIG Starts NexImmune at Buy With $5 Price Target

MT NewswiresJun 1, 2022 09:58 ET

Neximmune Initiated at Buy by BTIG

Dow JonesJun 1, 2022 07:39 ET

Neximmune Price Target Announced at $5.00/Share by BTIG

Dow JonesJun 1, 2022 07:39 ET

NexImmune analyst ratings

Benzinga Analyst RatingsJun 1, 2022 07:31 ET

BTIG Initiates Coverage On NexImmune with Buy Rating, Announces Price Target of $5

Benzinga Real-time NewsJun 1, 2022 07:30 ET